Anti-Human CD4 D3 Domain Recombinant Antibody

Name: Anti-Human CD4 D3 Domain Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1157

YR1157

科研级 Ibalizumab ( 伊巴组单抗 ), Anti-CD4 D3 Domain Recombinant Antibody, Research Grade Ibalizumab

DATASHEET MSDS

Product Description

Alias	科研级 Ibalizumab ( 伊巴组单抗 ), Anti-CD4 D3 Domain Recombinant Antibody, Research Grade Ibalizumab
Catalog Number	YR1157
Molecular Name	Ibalizumab
Host	Mouse
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	Ibalizumab (trade name Trogarzo) is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to the CD4 receptor on the surface of a CD4 cell.
CAS Number	680188-33-4
Application	FuncS, IF, Neut, ELISA, FCM, IP, ICC
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD4 D3 domain[Homo sapiens]

Login